Viewing nowSarpogrelate SR Tablet 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Albogene Korea Co., Ltd.

MFDS item code 201500372 · Approved 2015.01.23 · Insurance code 652604020
Improves ischemic symptoms (ulcer, pain, etc.) in chronic arterial occlusive disease
This medication is used to improve ischemic symptoms such as ulcers, pain, and cold sensation caused by chronic arterial occlusive disease. It is particularly effective in facilitating blood circulation and alleviating symptoms in conditions such as Buerger's disease, obstructive atherosclerosis, and diabetic peripheral vascular disease. By relieving these ischemic symptoms, it helps improve the quality of life of patients.
Administer 300 mg of Sarpogrelate Hydrochloride sustained-release tablets orally once daily after meals. This medication should be taken whole and not chewed or crushed.
This medication should not be used in patients with bleeding conditions, as it may worsen bleeding in states with risk such as hemophilia or gastrointestinal ulcers. It is advisable not to administer this medication to pregnant women or women who may become pregnant. Caution is advised when administering this drug to women during menstruation or patients with a tendency to bleed, and to those taking anticoagulants or antiplatelet agents. Patients with severely impaired renal function or elderly patients should also exercise caution. Various side effects such as urticaria, dyspepsia, diarrhea, headache, and cough may occur with this medication; therefore, any unusual symptoms should be reported to a healthcare professional immediately. If symptoms of bleeding, liver dysfunction, or blood abnormalities occur, the administration should be discontinued, and appropriate treatment should be sought. It is important to regularly conduct blood tests to monitor the condition during the use of this medication. The risk of bleeding may increase when used in conjunction with anticoagulants or antiplatelet agents, so caution is necessary when co-administering. Pregnant or breastfeeding women are advised not to use this medication, and if it must be used, breastfeeding should be avoided. The safety in pediatric patients has not been established, and there is no experience of use. This medication should be kept out of reach of children, and transferring it to another container should be avoided.
Urticaria, gastrointestinal bleeding (hematemesis and melena, etc.), cerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, erythema, palpitations, dyspnea, chest pain, dizziness, elevated blood pressure, atrial fibrillation, paralysis, confusion, visual disturbances, asthma attacks
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius. This will help preserve the effectiveness of the medication for a longer period.
White, oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Albogene Korea Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.